Skip to main content
Premium Trial:

Request an Annual Quote

Applied BioCode Inks US Distribution Deal With Medline Industries for MDx System, Test Menu

NEW YORK — Applied BioCode said on Monday that it has signed a US distribution agreement for its BioCode MDx-3000 automated molecular diagnostics system and other products with Medline Industries.

Under the terms of the deal, Northfield, Illinois-based Medline will distribute the BioCode MDx-3000 system, along with its menu of tests for upper respiratory and gastrointestinal infections, to clinical laboratory customers in the US. Medline will also distribute Applied BioCode's portfolio of analyte-specific reagents (ASRs), which are used to develop laboratory-developed tests.

Financial and other terms were not disclosed.

Applied BioCode has 510(k) clearances from the US Food and Drug Administration for its 17-plex Respiratory Pathogen Panel (RPP) and 17-plex Gastrointestinal Pathogen Panel (GPP), which are also CE marked. The Santa Fe Springs, California-based company also has received Emergency Use Authorization from the FDA for the BioCode CoV-2 Flu Plus Assay and BioCode SARS-CoV-2 Assay.

All of the tests run on the BioCode MDx-3000 system.

About a year ago, Applied BioCode inked an exclusive agreement for the US distribution of the diagnostic system, test menu, and ASRs with Hardy Diagnostics.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.